Stock Fundamentals

TRVN.US Logo

TRVN.US - Current Price

$0.01

Company Information

▼
Company Name
Trevena Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US89532E1091
CIK: 0001429560
CUSIP: 89532E109
Currency: USD
Full Time Employees: 23
Phone: 610 354 8840
Website: https://www.trevena.com
Fiscal Year End: December
IPO Date: Jan 31, 2014
Description:

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Address:

955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087

Directors & Officers

▼
Name Title Year Born
Ms. Carrie L. Bourdow President, CEO & Chairman 1963
Dr. Mark A. Demitrack M.D. Senior VP & Chief Medical Officer 1958
Dr. Howard A. Rockman M.D. Scientific Founder, Consultant and Member of Scientific Advisory Board NA
Ms. Katrine Sutton Principal Financial Officer & principal accounting officer 1977
Mr. Robert T. Yoder Senior VP, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer 1966
Mr. Michael Catalano Vice President of Marketing NA

Shares Statistics

▼
Shares Outstanding: 863.79K
Shares Float: 858.68K
% Insiders: 48.50%
% Institutions: 997.80%
Short % Float: 7.03%

Valuation Metrics

▼
Enterprise Value: $24.11M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $10.37K
EBITDA: $-31.75M
PEG Ratio: $0.00
Book Value: $-27.27
Earnings/Share: $-48.89
Profit Margin: 0.00%
Operating Margin: -1,970.67%
ROA (TTM): -62.39%
ROE (TTM): -1,014.58%
Revenue (TTM): $546.00K
Revenue/Share (TTM): $0.69
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 57.20%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2024 -5.79 -7.75 N/A 2,529.03%
Jun 30, 2024 -5.75 -10.12 N/A 4,318.18%
Mar 31, 2024 -0.36 -0.47 N/A 2,340.43%
Dec 31, 2023 -1.06 -0.38 N/A -17,894.74%
Sep 30, 2023 -0.57 -0.15 N/A -28,000.00%
Jun 30, 2023 -0.69 -1.05 N/A 3,428.57%
Mar 31, 2023 -0.81 -0.98 N/A 1,734.69%
Dec 31, 2022 -0.73 -1.75 N/A 5,828.57%
Sep 30, 2022 -2.25 -2.12 N/A -613.21%
Jun 30, 2022 -2.25 -2.56 N/A 1,210.94%
Mar 31, 2022 -2.50 -2.19 N/A -1,415.53%
Dec 31, 2021 -2.00 -2.50 N/A 2,000.00%
Sep 30, 2021 -2.00 -2.25 N/A 1,111.11%
Jun 30, 2021 -2.25 -1.83 N/A -2,295.08%
Mar 31, 2021 -1.50 -2.00 N/A 2,500.00%
Dec 31, 2020 -2.00 -1.50 N/A -3,333.33%
Sep 30, 2020 -1.00 -1.06 N/A 566.04%
Jun 30, 2020 -1.50 -1.62 N/A 740.74%
Mar 31, 2020 -1.50 -1.50 N/A 0.00%
Dec 31, 2019 -1.75 -2.12 N/A 1,745.28%
Sep 30, 2019 -2.25 -1.87 N/A -2,032.09%
Jun 30, 2019 -1.25 -2.00 N/A 3,750.00%
Mar 31, 2019 -1.50 -2.12 N/A 2,924.53%
Dec 31, 2018 -2.50 -1.87 N/A -3,368.98%
Sep 30, 2018 -1.50 -3.69 N/A 5,934.96%
Jun 30, 2018 -3.25 -3.33 N/A 240.24%
Mar 31, 2018 -3.50 -5.42 N/A 3,542.44%
Dec 31, 2017 -6.00 -6.68 N/A 1,017.96%
Sep 30, 2017 -6.75 -7.31 N/A 766.07%
Jun 30, 2017 -8.75 -9.02 N/A 299.33%
Mar 31, 2017 -9.00 -13.27 N/A 3,217.78%
Dec 31, 2016 -16.75 -15.42 N/A -862.52%
Sep 30, 2016 -14.25 -9.93 N/A -4,350.45%
Jun 30, 2016 -9.25 -8.97 N/A -312.15%
Mar 31, 2016 -8.75 -8.07 N/A -842.63%
Dec 31, 2015 -7.50 -6.39 N/A -1,737.09%
Sep 30, 2015 -6.00 -8.59 N/A 3,015.13%
Jun 30, 2015 -7.00 -9.44 N/A 2,584.75%
Mar 31, 2015 -8.25 -9.10 N/A 934.07%
Dec 31, 2014 -11.00 -12.94 N/A 1,499.23%
Sep 30, 2014 -14.75 -11.17 N/A -3,205.01%
Jun 30, 2014 -11.00 -9.83 N/A -1,190.23%
Mar 31, 2014 -14.75 -8.56 N/A -7,231.31%
Dec 31, 2013 -187.00 -12.75 N/A -136,666.67%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2023-12-31 $32.98M $N/A $40.61M $48.26M $-7.66M
2022-12-31 $38.32M $N/A $48.68M $33.08M $15.60M
2021-12-31 $66.92M $N/A $80.12M $15.50M $64.63M
2020-12-31 $109.40M $N/A $127.74M $23.67M $104.07M
2019-12-31 $32.31M $N/A $46.99M $16.92M $30.08M
2018-12-31 $32.89M $N/A $66.78M $25.25M $41.53M
2017-12-31 $16.56M $N/A $72.72M $38.09M $34.63M
2016-12-31 $24.27M $N/A $114.65M $36.07M $78.58M
2015-12-31 $46.77M $N/A $175.35M $32.22M $143.13M
2014-12-31 $36.21M $N/A $108.34M $9.13M $99.20M
2013-12-31 $37.97M $N/A $42.39M $3.40M $38.99M
2012-12-31 $6.74M $N/A $8.09M $8.13M $-39.18K
2011-12-31 $17.06M $N/A $19.41M $3.99M $15.42M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 28, 2022 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist